Ignite Creation Date:
2025-12-24 @ 3:02 PM
Ignite Modification Date:
2026-03-05 @ 12:30 AM
Study NCT ID:
NCT02309359
Status:
COMPLETED
Last Update Posted:
2019-08-21
First Post:
2014-11-27
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Dose-Range Finding Study for ALX-0061 Combination Therapy in Subjects With Rheumatoid Arthritis
Sponsor:
Ablynx, a Sanofi company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-01
Start Date Type:
None
Primary Completion Date:
2016-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-08
Completion Date Type:
ACTUAL
First Submit Date:
2014-11-27
First Submit QC Date:
None
Study First Post Date:
2014-12-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-06-12
Results First Submit QC Date:
None
Results First Post Date:
2019-08-21
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2017-09-06
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2019-08-06
Last Update Post Date:
2019-08-21
Last Update Post Date Type:
ACTUAL